JPRN-UMIN000023525已完成1 期
Phase I/II clinical trial for aGalCer resembling medicine,OCH in patients with Crohn s disease - OCH NCNP1
School of Medicine, Keio University Department of Internal Medicine0 个研究点目标入组 12 人开始时间: 2016年8月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patient who is suspected as other inflammatory bowel disease except Crohn s disease 2) Patient who will need bowel resection within 12 weeks after the entry of clinical trial. 3) Patient who is entering to another clinical trial or who receive medical treatment in any other clinical trial within 12 weeks prior to entry of the present clinical trial. others criteria can not uploaded due to the space.
研究者
相似试验
进行中（未招募）
1 期
ABORL - A Phase II trial aiming to evaluate the clinical interest of ABEMACICLIB in patients with locally advanced/metastatic head and neck cancer harboring an homozygous deletion of CDKN2A, and/or an amplification of CCND1 and/or of CDK6 refractory to standards treatmentsPatients with locally advanced/metastatic head and neck cancer after failure of platinum and cetuximab or anti-EGFR-basedMedDRA version: 20.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-004537-25-FRCentre Léon Bérard25
招募中
1 期
Clinical trial of vagus nerve stimulation therapy in patients with acute ST-elevation myocardial infarctioacute ST-elevation myocardial infarctionD000072657acute myocardial infarctionJPRN-jRCT2052230039oguchi Teruo20
进行中（未招募）
1 期
A phase IIa clinical trial to demonstrate the proof of concept of an experimental pediculicide lotion for the treatment of head liceEUCTR2005-005512-24-GBEctoPharma Limited20
进行中（未招募）
不适用
ocal treatment of bronchopleural fistula with adilts stem cellsEUCTR2012-000292-16-ESFundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP)
进行中（未招募）
1 期
Clinical trial to evaluate the safety and immune activation of DCVAC/PCa and ONCOS-102 in men with metastatic prostate cancer.advanced metastatic castration-resistant prostate cancerMedDRA version: 20.0Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004314-15-CZSOTIO a.s.15